000516.SZ
国际医学
SZSE · Healthcare · Q 卫生 · CN
CNY 4.09
−2.39%Year over year
Reported trailing growth
- Revenue
- -12.8%
- EBITDA
- —
- EBIT
- -0.0%
- EPS
- -3.4%
- Free cash flow
- +114.0%
- Operating cash flow
- +24.0%
Forward estimates
Based on analyst estimates
- Revenue
- -67.3%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +14.5%
- EBITDA
- -2.7%
- EBIT
- -17.0%
- Net income
- -23.2%
- EPS
- -27.3%
- Free cash flow
- +76.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026